Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-17

Clinical Trial Update: A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPD [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 study evaluating the safety and efficacy of infliximab (Remicade) in patients with chronic obstructive pulmonary d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remicade (infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Chronic Obstructive Pulmonary Disease, COPD | Phase 3 | Status: COMPLETED